Skip to content

Prognostic value of serum inflammatory markers in patients with anastomotic lesions after Crohn's disease

Prognostic value of serum inflammatory markers in patients with anastomotic lesions after Crohn's disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058062
Enrollment
Unknown
Registered
2022-03-28
Start date
2022-04-15
Completion date
Unknown
Last updated
2023-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's disease (CD)

Interventions

relapse free group:None

Sponsors

The First Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
13 Years to 66 Years

Inclusion criteria

Inclusion criteria: 1. CD patients who received ileocolectomy in the First Affiliated Hospital of Sun Yat-Sen University or the Sixth Affiliated Hospital of Sun Yat-sen University in Guangzhou, China from January 2013 to December 2020. 2. Diagnosis based on clinical symptoms, back colonoscopy, histopathology and radiological evidence. 3. The initial endoscopy performed after surgery revealed anastomotic ulcers ±<5 Avthar ulcers at the new terminal ileum (i2a of modified Rutgeerts score [MRS]). 4. Available data of complete blood count within one week before and after initial endoscopy. 5. Follow up for at least 3 months.

Exclusion criteria

Exclusion criteria: Patients with postoperative infection, re-operation within 3 months after surgery, or other autoimmune diseases.

Design outcomes

Primary

MeasureTime frame
ileocoloscopy;

Countries

China

Contacts

Public ContactZhang Shenghong

Department of Gastroenterology, the First Affiliated Hospital, Sun Yat-sen University

shenghongzhang@163.com+86 13570527027

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026